These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33591951)

  • 1. Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study.
    Zhang W; Sang L; Shi J; Zhong M; Jiang L; Song B; Kang L; Zhang Y; Zhang D; Yu Y; Zheng X
    Aging (Albany NY); 2021 Feb; 13(4):4794-4810. PubMed ID: 33591951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.
    Manzoor D; Bui C; Makhoul E; Luthringer D; Marchevsky A; Volod O
    Medicine (Baltimore); 2021 Apr; 100(15):e25255. PubMed ID: 33847623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.
    Zhang L; Yan X; Fan Q; Liu H; Liu X; Liu Z; Zhang Z
    J Thromb Haemost; 2020 Jun; 18(6):1324-1329. PubMed ID: 32306492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.
    Nugroho J; Wardhana A; Maghfirah I; Mulia EPB; Rachmi DA; A'yun MQ; Septianda I
    Int J Lab Hematol; 2021 Feb; 43(1):110-115. PubMed ID: 32931146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].
    Zhang J; Gao XL; Li DJ; Jiang Y; Liu Y; Pang L; Xu D; Yang LH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):927-931. PubMed ID: 33333696
    [No Abstract]   [Full Text] [Related]  

  • 10. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019.
    Short SAP; Gupta S; Brenner SK; Hayek SS; Srivastava A; Shaefi S; Singh H; Wu B; Bagchi A; Al-Samkari H; Dy R; Wilkinson K; Zakai NA; Leaf DE;
    Crit Care Med; 2021 May; 49(5):e500-e511. PubMed ID: 33591017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.
    Yue J; Xu H; Zhou Y; Liu W; Han X; Mao Q; Li S; Tam LS; Ma J; Liu W
    Front Endocrinol (Lausanne); 2021; 12():611526. PubMed ID: 34248834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.
    Kocayiğit H; Özmen Süner K; Tomak Y; Demir G; Kocayiğit İ; Yaylacı S; Aydemir Y; Köroğlu M; Karabay O; Öztürk MH; Erdem AF
    Turk J Med Sci; 2021 Apr; 51(2):440-447. PubMed ID: 33185365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of a new quantitative D-dimer test in critically ill patients 24 and 48 h following admission to the intensive care unit.
    Shitrit D; Izbicki G; Shitrit AB; Kramer MR; Rudensky B; Sulkes J; Hersch M
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):15-9. PubMed ID: 15166938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases.
    Shi J; Zhang W; Sang L; Qu Z; Zhong M; Jiang L; Song B; Kang L; Zhang Y; Wang X; Zhang D; Zheng X
    Aging (Albany NY); 2020 Dec; 13(2):1591-1607. PubMed ID: 33318314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DVT incidence and risk factors in critically ill patients with COVID-19.
    Chen S; Zhang D; Zheng T; Yu Y; Jiang J
    J Thromb Thrombolysis; 2021 Jan; 51(1):33-39. PubMed ID: 32607652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
    An H; Zhang J; Zhou T; Li T; Li S; Huang C; Chen C; Ying B; Xu Z; Jin S; Li X; Li M
    Clin Immunol; 2021 Nov; 232():108852. PubMed ID: 34520860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.
    Ibrahim ME; Al-Aklobi OS; Abomughaid MM; Al-Ghamdi MA
    PLoS One; 2021; 16(4):e0250955. PubMed ID: 33914805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Is the Impact of Baseline Inflammatory and Hemostatic Indicators with the Risk of Mortality in Severe Inpatients with COVID-19: A Retrospective Study.
    Zhu H; Li Y; Su H; Yan C; Xin W; Ying K
    Clin Appl Thromb Hemost; 2024; 30():10760296241255959. PubMed ID: 38831596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.